Glooko In the News
Consolidation Surge Hits Healthtech
Glooko, a leading provider of digital-health and remote-patient monitoring systems for diabetes, acquired Monarch Medical Technologies, adding an inpatient...
Read MoreFDA clears Glooko’s cloud-based insulin dosing platform
Ideating on Glooko’s existing EndoTool system, the cloud-based version is designed to support more scalable deployment across hospital settings.
FDA Grants 510(k) Clearance for Glooko’s EndoTool IV Cloud Insulin Dosing Platform
Glooko has received U.S. FDA 510(k) clearance for EndoTool IV Cloud, making it the first cloud-based, patient-specific insulin dosing platform cleared...
FDA Clears Glooko’s Cloud Platform for IV Insulin Dosing
Glooko has won FDA clearance for EndoTool IV Cloud, a cloud-based patient-specific insulin dosing platform that supports individualized insulin dosing...
Glooko wins FDA clearance for cloud-based insulin dosing platform
Glooko announced that the FDA granted 510(k) clearance for its EndoTool IV Cloud, a cloud-based, patient-specific insulin dosing platform.
FDA Clears EndoTool IV Cloud for Inpatient IV Insulin Dosing Support
The US FDA cleared the EndoTool IV Cloud, a cloud-based version of parent company Glooko’s inpatient intravenous insulin dosing decision-support platform,...
MyLife Diabetes Care, Glooko expand partnership
Glooko and MyLife Diabetes Care announced that they agreed to expand their partnership centered around diabetes management products.
EndoTool IV Eliminates Severe Hypoglycemia
Data presented at the 2026 AACE Annual Meeting showed that EndoTool IV, Glooko’s inpatient glycemic management solution, achieved an impressive 98% reduction...
Dartmouth Diabetes Initiative funds diabetes education and management
Glooko sponsored the second annual Diabetes Dash 5K Run, organized by the Dartmouth Diabetes Initiative, which raised over $8,500 for diabetes education.
Glooko data backs insulin dosing platform
At AACE 2026, Glooko presented data demonstrating that EndoTool IV achieved a 98% reduction in severe hypoglycemia across a 19-hospital health system when...
How Temple Health is deploying AI and informatics to advance patient safety and physician performance
By implementing the EndoTool predictive insulin-dosing platform, Temple Health achieved a two- to three-fold reduction in inpatient hypoglycemic events...
How Glooko Turns 3B+ Data Points Per Month into Lifesaving Diabetes Healthcare with Tiger Data
Per Grapatin, Vice President of Engineering at Glooko, shares how the digital health company migrated more than 100 million daily glucose readings in its...
Glycemic safety under CMS scrutiny: Where performance gaps emerge and how leaders are closing them
During a Becker’s Healthcare webinar hosted by Glooko, four healthcare leaders explored where glycemic safety efforts commonly fall short and what it...
Glooko to Integrate Roche’s Accu-Chek SmartGuide CGM in Latest Partnership
The collaboration allows Accu-Chek's CGM data to flow into the Glooko diabetes management platform, giving care teams a single dashboard to review glucose...
Glooko integrates with Roche Accu-Chek CGM
Glooko is expanding its diabetes management platform capabilities by integrating the Roche Accu-Chek SmartGuide CGM across select European countries.
Glooko integrates diabetes management tech with Roche CGM
Glooko announced that it agreed to integrate its diabetes management platform with the Roche Accu-Chek SmartGuide CGM to reduce the administrative burden...
Glooko to Expand EMEA CGM Connectivity
Glooko announced a new integration with Roche’s Accu-Chek SmartGuide CGM in select European countries, allowing patients to view their CGM data alongside...
How Mike Alvarez is Tackling Diabetes’ Tower of Babel
As Glooko CEO, Mike Alvarez is working to dismantle the "Tower of Babel" in diabetes care through our device agnostic diabetes management platform while...